FALCON POINT CAPITAL, LLC

Holdings History for LIGAND PHARMACEUTICALS INC - Common Stock (LGND)

Symbol: LGND on Nasdaq
Investment type: Equity / Common Stock

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2020		-1.6%	$0	0	-2,871	-100%	$183.98	Q3 2020
30 Jun 2020	1.6%	-2.2%	$321,000	2,871	-4,054	-59%	$111.81	Q2 2020
31 Mar 2020	1.1%	-0.19%	$504,000	6,925	-1,190	-15%	$72.78	Q1 2020
31 Dec 2019	1.1%	-3.3%	$846,000	8,115	-24,711	-75%	$104.25	Q4 2019
30 Sep 2019	2.1%	+0.11%	$3,572,000	32,826	+1,694	+5.4%	$108.82	Q3 2019
30 Jun 2019	1.9%	+0.04%	$3,554,000	31,132	+627	+2.1%	$114.16	Q2 2019
31 Mar 2019	2.1%	+0.46%	$3,835,000	30,505	+6,654	+28%	$125.72	Q1 2019
31 Dec 2018	1.9%	-1.6%	$3,237,000	23,851	-20,082	-46%	$135.72	Q4 2018
30 Sep 2018	2.6%	-0.76%	$12,059,000	43,933	-12,814	-23%	$274.49	Q3 2018
30 Jun 2018	2.3%	-0.96%	$11,756,000	56,747	-23,721	-29%	$207.17	Q2 2018
31 Mar 2018	2.7%	-0.53%	$13,290,000	80,468	-15,961	-17%	$165.16	Q1 2018
31 Dec 2017	2.2%	-0.44%	$13,204,000	96,429	-19,168	-17%	$136.93	Q4 2017
30 Sep 2017	2.8%	-0.14%	$16,802,000	115,597	-5,714	-4.7%	$145.35	Q3 2017
30 Jun 2017	2%	-0.06%	$14,727,000	121,311	-3,686	-2.9%	$121.40	Q2 2017
31 Mar 2017	1.8%	-0.55%	$13,230,000	124,997	-39,249	-24%	$105.84	Q1 2017
31 Dec 2016	2.2%	+0.17%	$16,689,000	164,246	+12,140	+8%	$101.61	Q4 2016
30 Sep 2016	2.3%	+1.4%	$14,561,000	152,106	+93,137	+158%	$95.73	Q3 2016
30 Jun 2016	1.2%	-0.89%	$7,033,000	58,969	-43,294	-42%	$119.27	Q2 2016
31 Mar 2016	1.9%	+0.78%	$10,951,000	102,263	+41,959	+70%	$107.09	Q1 2016
31 Dec 2015	1.4%	+0.69%	$6,538,000	60,304	+29,313	+95%	$108.42	Q4 2015
30 Sep 2015	0.95%	+0.95%	$2,654,000	30,991	+30,991	NEW	$85.64	Q3 2015

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.